My Genome Screen
PrivateLast Round
Accelerator
May 20, 2024
Total Funding Raised
$30,000
Company Overview
My Genome Screen is a decision/risk analysis company that operates a personalized health diagnostics service using AI and genomic data to provide diagnoses, health alerts, and lifestyle recommendations for genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
My Genome Screen Comparables
Compare My Genome Screen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Breakthrough Genomics | 82% | |
| enGenome | 81% | |
| Saphetor | 79% | |
My Genome Screen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 20, 2024 |
Key People
Founding team and executive leadership
My Genome Screen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sabancı ARF | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2024
$30K raised from Sabancı ARF
My Genome Screen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about My Genome Screen's valuation, stock price, and market status.